Article

Stone recurrence: Advice for young urologists

In this video, Juan Calle, MD, of Cleveland Clinic, explains what he would tell a young urologist who wants to become an expert in stone prevention and minimizing recurrence.

Juan Calle, MD, of Cleveland Clinic, explains what he would tell a young urologist who wants to become an expert in stone prevention and minimizing recurrence.

Related Videos
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
John Michael DiBianco, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Perry Xu, MD, answers a question during Zoom video interview
Related Content
Stent omission after ureteroscopy is safe, improves patient-reported outcomes
May 8th 2025

Stent omission after ureteroscopy is safe, improves patient-reported outcomes

Hannah Clarke
Patient-reported pain scores were significantly improved with stent omission.
Dr. Schwen on focal therapies for prostate cancer
January 11th 2024

Dr. Schwen on focal therapies for prostate cancer

Cleveland Clinic
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
Kidney stones | Image Credit: © airborne77 - stock.adobe.com
April 28th 2025

CVAC 2.0 demonstrates efficacy for clearing stones less than 2 cm

Benjamin P. Saylor
The investigators reported a median stone clearance of 96.44%.
Why kidney stones will become more prevalent over time
February 17th 2022

Why kidney stones will become more prevalent over time

Urology Times staff
“The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.
Pivotal trial of Break Wave System for stone disease reaches enrollment goal
April 24th 2025

Pivotal trial of Break Wave System for stone disease reaches enrollment goal

Hannah Clarke
Data from the SOUND trial are intended to support submission for FDA 510(k) clearance of the Break Wave device.
BWL plus ultrasonic propulsion shows safety, efficacy for small renal stones
April 18th 2025

BWL plus ultrasonic propulsion shows safety, efficacy for small renal stones

Hannah Clarke
Overall, 71% of patients had no fragment greater than 2 mm following treatment.
© 2025 MJH Life Sciences

All rights reserved.